Giselle Guerra is a Nephrology physician affiliated with University of Miami. OpenAlex indexes 179 publications with 2,976 citations (h-index 29); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1611 NW 12th Ave
Box 016960 M851
Miami, FL 331361005
Telephone
305-585-1111Registry record last updated 9 Sept 2014.
Clinical trials
- COVID-19 3rd Dose Vaccine in Transplant Patients
Sponsor: Giselle Guerra
- XM-One Study for Living Donor Program
Sponsor: University of Miami
- CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients
Sponsor: University of Florida
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Dilon Technologies, Inc.Program year20251 payment
- Dilon Technologies, Inc.Program year20241 payment
- ABIOMEDProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
40.7%Selective T Cell Costimulation Blocker40.7%Nulojix100%Part D<11 patientsMetabolism & gastrointestinal
35.2%H2 blocker35.2%Famotidine100%Part D<11 patientsAnti-infectives
24.1%Sulfone24.1%Dapsone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2017–2022 per NIH RePORTER. The latest:
- 1/13 ApoL1 Genotypes in Kidney Donors and Long-Term Outcomes in Kidney Transplant Recipients Clinical Center
University of Miami School of Medicine
FY2022$303,659U01DK116101 - 1/13 ApoL1 Genotypes in Kidney Donors and Long-Term Outcomes in Kidney Transplant Recipients Clinical Center
University of Miami School of Medicine
FY2020$133,334U01DK116101 - 1/13 ApoL1 Genotypes in Kidney Donors and Long-Term Outcomes in Kidney Transplant Recipients Clinical Center
University of Miami School of Medicine
FY2019$343,356U01DK116101
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Is the Omicron variant truly less virulent in solid organ transplant recipients?
Transplant Infectious Disease
2022 - Changing trends in mortality among solid organ transplant recipients hospitalized for COVID-19 during the course of the pandemic
American Journal of Transplantation
2021 - COVID-19 in hospitalized lung and non-lung solid organ transplant recipients: A comparative analysis from a multicenter study
American Journal of Transplantation
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Myerburg, MD
University of Miami
Thomas Hooton, MD
University of Miami
Harry Flynn, MD
University of Miami
Alan Wein, MD
University of Miami
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”